Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

Has over 150 years of combined biotech/pharma industry experience

Has been directly involved in over 35 Investigational New Drug applications (INDs)

Are responsible for 70 therapeutics currently in the clinic

Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate Project Manager Heique Bogdawa will be a panelist at the @UqPef Protein Expression Workshop next week. For more details, visit https://bit.ly/3Qk7r2K

Thanks @davidkchalmers exciting to be able to progress our long-term multidisciplinary collaboration in #hiv drug discovery thanks to support from @BioCurate @MIPS_Australia @BurnetInstitute https://twitter.com/davidkchalmers/status/1555002846592258048

@MIPS_Australia and @BurnetInstitute has teamed up to develop next generation antivirals with funding from @BioCurate.

The team, led by @davidkchalmers and @GildaTachedjian, has identified a new way to attack HIV.


Researchers from @BurnetInstitute & @MIPS_Australia have received funding from @BioCurate to develop next-generation HIV antivirals.

The team, led jointly by @GildaTachedjian & @davidkchalmers, has identified a new way to attack HIV.

Read more: https://burnet.edu.au/news/1658_burnet_teams_up_with_monash_and_biocurate_to_develop_novel_hiv_antivirals